Heart Transplantation-The Pediatric Cardiac Critical Care Perspective.
Year of Publication
Number of Pages
<p><strong>OBJECTIVES: </strong>Although there have been tremendous advancements in the care of severe pediatric cardiovascular disease, heart transplantation remains the standard therapy for end-stage heart disease in children. As such, these patients comprise an important and often complex subset of patients in the ICU. The purpose of this article is to review the causes and management of allograft dysfunction and the medications used in the transplant population.</p>
<p><strong>DATA SOURCES: </strong>MEDLINE, PubMed, and Cochrane Database of systemic reviews.</p>
<p><strong>CONCLUSIONS: </strong>Pediatric heart transplant recipients represent a complex group of patients that frequently require critical care. Their immunosuppressive medications, while being vital to maintenance of allograft function, are associated with significant short- and long-term complications. Graft dysfunction can occur from a variety of etiologies at different times following transplantation and remains a major limitation to long-term posttransplant survival.</p>
Pediatr Crit Care Med